Walleye Trading’s Trillium Therapeutics Inc. TRIL Stock Holding History

Walleye Trading’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,400	Closed	-$112K	–	6242
2021 Q3	$112K	Buy	+6,400	New	+$74.8K	﹤0.01%	4304
2015 Q4	–	Sell	-100	Closed	-$1K	–	5869
2015 Q3	$1K	Sell	100 -300	-75%	-$5.51K	﹤0.01%	4858
2015 Q2	$9K	Buy	+400	New	+$9.12K	﹤0.01%	4346

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Walleye Trading's TRIL Position: Q4 2021 in Review

Walleye Trading sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 6,400 shares — an estimated $112K sold.

Walleye Trading first reported a position in TRIL in Q2 2015 and held it in 3 quarters. The position peaked at $112K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Walleye Trading reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Walleye Trading sold 6,400 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $112K.
Walleye Trading first reported a position in Trillium Therapeutics Inc. in Q2 2015 and held it in 3 quarters.
Walleye Trading's Trillium Therapeutics Inc. position peaked at $112K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Walleye Trading's 13F filing for Q4 2021, filed 14 Feb 2022.